Literature DB >> 2365705

Bradykinin transiently activates protein kinase C in Swiss 3T3 cells. Distinction from activation by bombesin and vasopressin.

M Issandou1, E Rozengurt.   

Abstract

The results presented here demonstrate that bradykinin, acting through a B2 subtype receptor, induces a unique pattern of early signals in quiescent Swiss 3T3 cells. Bradykinin caused a rapid mobilization of calcium from internal stores, as judged by measurements of intracellular Ca2+ concentration in fura-2-loaded cells and by 45Ca2+ efflux from radiolabeled cells. Analysis of phosphoproteins from 32P-labeled Swiss 3T3 cells by one- and two-dimensional gel electrophoresis revealed that bradykinin stimulated transient phosphorylation of an acidic cellular protein migrating with an apparent Mr = 80,000 (termed 80K), identified as a major and specific substrate of protein kinase C. Down-regulation of protein kinase C by pretreatment with phorbol 12,13-dibutyrate (PDBu) completely abolished the increase in 80K phosphorylation. In contrast to the sustained effect induced by bombesin, vasopressin, or PDBu, the stimulation of 80K phosphorylation by bradykinin reached a maximum after 1 min of incubation, and then it rapidly decreased to almost basal levels. Furthermore, bradykinin did not induce protein kinase C-mediated events such as inhibition of 125I-epidermal growth factor binding or enhancement of cAMP accumulation. Bombesin and vasopressin elicited both responses in parallel cultures. Bradykinin induced rapid accumulation of total inositol phosphates in cells labeled with myo-[3H]inositol. In contrast to bombesin and vasopressin which stimulated a linear increase in inositol phosphate accumulation over a 10-min period, the effect of bradykinin reached a plateau after 2.5 min of incubation with no further increase up to 10 min. The results demonstrate that the early signaling events triggered by bradykinin can be distinguished from those elicited by bombesin and vasopressin in Swiss 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365705

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Transduction of the bradykinin response in human fibroblasts: prolonged elevation of diacylglycerol level and its correlation with protein kinase C activation.

Authors:  B G Etscheid; K A Albert; M L Villereal; H C Palfrey
Journal:  Cell Regul       Date:  1991-03

2.  Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Authors:  Z K Pan; B L Zuraw; C C Lung; E R Prossnitz; D D Browning; R D Ye
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes.

Authors:  N J Reynolds; H S Talwar; J J Baldassare; P A Henderson; J T Elder; J J Voorhees; G J Fisher
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

4.  Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.

Authors:  C Liebmann; A Graness; B Ludwig; A Adomeit; A Boehmer; F D Boehmer; B Nürnberg; R Wetzker
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

5.  Bradykinin increases intracellular calcium levels in rat testis peritubular cells via the B2 receptor subtype.

Authors:  Gunther Wennemuth; Sonja Blöcher; Wolf-Bernhard Schill; Gerhard Aumüller; Thomas K Monsees
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

6.  The effects of phorbol ester on slowly conducting afferents of the cat's knee joint.

Authors:  K Schepelmann; K Messlinger; R F Schmidt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma.

Authors:  T Ozeki; K Osada; M Seishima; S Mori; Y Nozawa
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 8.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

9.  Protein kinase C activation potently down-regulates the expression of its major substrate, 80K, in Swiss 3T3 cells.

Authors:  S F Brooks; T Herget; J D Erusalimsky; E Rozengurt
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

10.  Second messengers regulate endosomal acidification in Swiss 3T3 fibroblasts.

Authors:  K Zen; J Biwersi; N Periasamy; A S Verkman
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.